Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention

Table 1 Liver function tests of rats under MSG-induced obesity and probiotic correction

Parameters	Control rats (n = 10)	MSG-induced obesity (n = 10)	B. animalis VKL (n = 10)	B. animalis VKB (n = 10)	L. casei IMVB-7280 (n = 10)	Poliprobiotics (n = 10)	Symbiter (n = 10)
Total bilirubin, umol/l	12.9 ± 0.73	12.6 ± 0.58	13.6 ± 0.68	12.5 ± 0.3	13.3 ± 0.63	12.4 ± 0.47	13.4 ± 0.63
Indirect bilirubin, umol/l	8.3 ± 0.55	8.2 ± 0.35	8.6 ± 0.47	8.2 ± 0.29	8.5 ± 0.5	8.3 ± 0.33	8.3 ± 0.53
Direct bilirubin, mmol/l	4.6 ± 0.33	4.4 ± 0.3	5.0 ± 0.29	4.3 ± 0.26	4.8 ± 0.29	4.1 ± 0.27	5.1 ± 0.23
ALT, mkkat/l	0.231 ± 0.011	0.243 ± 0.015	0.230 ± 0.013	0.209 ± 0.010	0.221 ± 0.008	0.211 ± 0.014	0.212 ± 0.007
AST, mkkat/l	0.386 ± 0.007	0.397 ± 0.011	0.396 ± 0.015	0.382 ± 0.011	0.389 ± 0.014	0.373 ± 0.016	0.381 ± 0.018

Data are presented as the M ± SEM. One-way ANOVA or Kruskall-Wallis test were performed for data analysis. All differences were not significant (p > 0.05)